Companies /Healthcare
Tilray Brands Inc
NASDAQ: TLRY Drug Manufacturers - Specialty & Generic
$3.21
▲ $0.07 (+2.23%) today
Markets closed · 12:41am ET

Tilray Brands (TLRY) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
33%
EPS beat rate
−24.41%
Avg. EPS surprise
Consecutive EPS misses
TLRY vs Market · 30-day return after each reportTLRYS&P 500
0%+60%+120%+154.8%+2.2%Q4 25−37.6%+1.5%Q1 26−17.0%−0.3%Q2 26−3.9%+9.6%Q3 26+15.0%+5.5%Q4 26
0%+60%+120%Q4 25Q1 26Q2 26Q3 26Q4 26
TLRY EPS Trend · estimate vs actualEstimateActual
$0.00$0.07$0.14$0.21$0.00$0.02Q4 25$0.00$0.00Q1 26$0.00$-0.02Q2 26$0.07$0.02Q3 26$0.21$0.05Q4 26$0.04$-0.02Q1 27
$0.00$0.07$0.14$0.21Q4 25Q2 26Q4 26
TLRY Revenue Trend · estimate vs actualEstimateActual
$0$80.0M$160.0M$240.0M$233.3M$224.5MQ4 25$205.8M$209.5MQ1 26$211.1M$217.5MQ2 26$201.3M$206.7MQ3 26$246.3M$281.7MQ4 26$267.8M$257.1MQ1 27
$0$80.0M$160.0M$240.0MQ4 25Q2 26Q4 26

How Often Does Tilray Brands Beat Earnings Estimates?

Tilray Brands beat EPS estimates in 2 of its last 6 reported quarters, and has missed 4 quarters in a row.

TLRY quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q1 2027 $-0.02 est. $0.04 −150.00% $257.1M est. $267.8M −3.97%
Q4 2026 $0.05 est. $0.21 −76.19% $281.7M est. $246.3M +14.38%
Q3 2026 $0.02 est. $0.07 −71.43% $206.7M est. $201.3M +2.70%
Q2 2026 $-0.02 est. $0.00 — $217.5M est. $211.1M +3.01%
Q1 2026 $0.00 est. $0.00 — $209.5M est. $205.8M +1.82%
Q4 2025 $0.02 est. $0.00 +200.00% $224.5M est. $233.3M −3.75%

Figures from SEC filings and company reports. Not investment advice.